pipobroman
Sign in to saveAlso known as A-8103, Vercyte®, Vercyte
Pipobroman (trade names Vercite, Vercyte) is an anti-cancer drug that probably acts as an alkylating agent, and is marketed in France and Italy.
Research
118 papers- Treatment of polycythemia vera and essential thrombocythemia: the role of pipobroman.Leukemia & lymphoma · 2003
- Bone marrow aplasia after pipobroman: an immune-mediated mechanism?British journal of haematology · 2001
- Long-term incidence of hematological evolution in three French prospective studies of hydroxyurea and pipobroman in polycythemia vera and essential thrombocythemia.Seminars in thrombosis and hemostasis · 2006
- Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study.Leukemia · 2013
- Polycythemia vera.Internal and emergency medicine · 2010
via PubMed
Wikidata facts
- Mass
- 353.957851952
Show 2 more facts
- chemical formula
- C₁₀H₁₆Br₂N₂O₂
- canonical SMILES
- C1CN(CCN1C(=O)CCBr)C(=O)CCBr
via Wikidata · CC0
~1 min read
Article
1 sectionsContents
- References
Pipobroman (trade names Vercite, Vercyte) is an anti-cancer drug that probably acts as an alkylating agent, and is marketed in France and Italy.
== References ==
Available in 9 languages
via Wikidata sitelinks · CC0
Connections
tiazofurin
Entity
medication
Entity
digital object identifier
Entity
chemical formula
Entity
chemotherapy
Entity
molar mass
Entity
Q180686
Entity
DNA replication
Entity
hydrazine
Entity
cell cycle
Entity
DL-asparagine
Entity
CAS Registry Number
Entity
PubChem
Entity
microtubule
Entity
Anatomical Therapeutic Chemical Classification System
Entity
gene therapy
Entity
arsenic trioxide
Entity
sex steroid
Entity
clinical trial
Entity
World Health Organization Model List of Essential Medicines
Entity